as 12-20-2024 2:40pm EST
NKGen Biotech Inc is a biotechnology company developing cell therapies for neurodegenerative and oncological diseases based on activated NK cells. NK cells are part of the human innate immune response system that can selectively identify and destroy abnormal or diseased cells. Its product candidates are based on a proprietary manufacturing and cryopreservation process that produces SuperNKTM (SNK) cells that have shown increased activity as compared to the starting population of NK cells, based on the results of in vitro experiments performed by NKMAX, as defined by parameters such as cytotoxicity, cytokine production and activating receptor expression. SNK cells can be produced in large quantities and cryopreserved while maintaining high levels of cytotoxicity.
Founded: | 2017 | Country: | United States |
Employees: | N/A | City: | SANTA ANA |
Market Cap: | 14.1M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 573.8K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.35 | EPS Growth: | N/A |
52 Week Low/High: | $0.20 - $4.06 | Next Earning Date: | 12-31-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
NKGN Breaking Stock News: Dive into NKGN Ticker-Specific Updates for Smart Investing
GlobeNewswire
20 days ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
GlobeNewswire
4 months ago
GlobeNewswire
4 months ago
The information presented on this page, "NKGN NKGen Biotech Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.